Results 121 to 130 of about 36,908 (274)

Sarcopenia and the frailty progression among Chinese: a longitudinal study

open access: yesFrontiers in Public Health
IntroductionPrevious studies primarily focused on baseline sarcopenia status, neglecting changes over time. This study aims to explore the association between changes in sarcopenia status and frailty progression, hypothesizing that transitions to ...
Xingyu Mu   +4 more
doaj   +1 more source

Sarcopenia - Endocrinological and neurological aspects. [PDF]

open access: yes, 2019
Sarcopenia in geriatric patients is often associated with or even caused by changes of the endocrine and nervous system. The multifactorial pathogenesis of sarcopenia and additional multimorbidity in geriatric patients makes it difficult to study ...
Stangl, M.K.   +16 more
core   +1 more source

Interactive Roles of Metabolic Dysfunction‐Associated Steatotic Liver Disease and Nutritional Status in the Prognosis of Patients With Hepatocellular Carcinoma After Surgical Resection

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The prognostic effect of concurrent metabolic dysfunction‐associated steatotic liver disease (MASLD) on outcomes for hepatocellular carcinoma (HCC) patients remains unclear. The Prognostic Nutritional Index (PNI) reflects nutritional and inflammatory status and is a well‐known prognostic factor.
Chun‐Ting Ho   +10 more
wiley   +1 more source

Harnessing immunomodulation to combat sarcopenia: current insights and possible approaches

open access: yesImmunity & Ageing
Sarcopenia is a complex age-associated syndrome of progressive loss of muscle mass and strength. Although this condition is influenced by many factors, age-related changes in immune function including immune cell dynamics, and chronic inflammation contribute to its progression.
Ning Zhang   +7 more
openaire   +3 more sources

Possible sarcopenia, sarcopenic obesity phenotypes and their association with diabetes: Evidence from LASI wave-1 (2017-18) [PDF]

open access: yes
Aims To assess the prevalence of possible sarcopenia and sarcopenic obesity phenotypes and investigate their association with self-reported diabetes among community-dwelling individuals aged 45 or above.
Chandel, Shivani   +3 more
core   +1 more source

Sarcopenia: a rising geriatric giant: health and economic outcomes of community-dwelling older adults with sarcopenia [PDF]

open access: yes, 2016
Future government policy assumes that elderly people will live at home independently for as long as possible instead of relying on care services. This requires a proactive policy to prevent vulnerability. Elderly people often suffer from poor muscle mass
Mijnarends, Donja Marita
core   +1 more source

Sarcopenia as a severe organ failure, its diagnosing and present therapeutic possibilities [PDF]

open access: yesVnitřní lékařství, 2018
Sarcopenia is defined as generalized and progressive age-related loss of skeletal muscle mass, muscle strength and physical performance below a defined threshold. In sarcopenia skeletal muscle mass - the largest body organ - is failing in its function and the term "muscle failure" was suggested.
openaire   +2 more sources

Unintentional Weight Loss Does Not Predict Poor Outcomes in Zenker Diverticulum

open access: yesThe Laryngoscope, EarlyView.
In this study of 427 patients with Zenker's diverticulum, 23.6% had significant unintentional preoperative weight loss. Weight loss was associated with preoperative dysphagia and with both the smallest and largest pouches. Postoperative outcomes were similar in patients with and without weight loss, demonstrating a similar efficacy and safety profile ...
Ari D. Schuman   +31 more
wiley   +1 more source

Proteomic Signatures of Ectopic Fat Distribution: Tissue‐Specific Drivers and Clinical Implications

open access: yesMed Research, EarlyView.
Integration of plasma proteomics and multi‐organ MRI in 666 UK Biobank participants, combined with a knockoff‐based causal inference and machine learning framework, reveals organ‐specific drivers of ectopic fat: PLA2G1B (pancreas), ERBB2/IGFBP2 (liver), CA14 (muscle), and NCAM2/TNFRSF10B (pericardium). These drivers engage distinct pathways (e.g., PI3K‐
Bing Zhang   +9 more
wiley   +1 more source

Senotherapeutics for Knee Osteoarthritis

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Osteoarthritis (OA) is a chronic disease that imposes a significant economic burden and deteriorates quality of life. Nevertheless, current therapeutic options for OA are limited to symptomatic remedies. As such, there is a high interest in novel methods for treating or preventing OA.
Ezgi Duman   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy